Clinical Trials Directory

Trials / Terminated

TerminatedNCT00332839

Comparison of CNI-based Regimen Versus CNI-free Regimen in Kidney Transplant Recipients.

Multi-center, Open-label, Prospective, Randomized, Parallel Group Study Investigating a CNI-free Regimen With Enteric-coated Mycophenolate Sodium and Everolimus in Comparison to Standard Therapy With Enteric-coated Mycophenolate Sodium and Ciclosporin Microemulsion in Stable Renal Transplant Patients

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
93 (actual)
Sponsor
Novartis Pharmaceuticals · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Calcineurin inhibitors (CNI), a potent immunosuppressive drug used in kidney transplant recipients to prevent graft rejection, may cause renal impairment. The aim of this study is to assess whether a CNI-free regimen with enteric-coated mycophenolate sodium and everolimus is as safe and well tolerated as a standard regimen consisting of enteric-coated mycophenolate sodium and cyclosporine microemulsion without a compromise in therapeutic efficacy while resulting in an improved renal function.

Conditions

Interventions

TypeNameDescription
DRUGEverolimusParticipants, switching from the CsA based treatment, initially received everolimus 1.5 mg/day and then from day 7, 3 mg/day, and then from day 14, the dose was based on the participants' blood level (6-10 ng/ml). Participants, switching from the tacrolimus based treatment, initially received 3 mg/day and then from day 14, the dose was based on the participants' blood level (6-10 ng/ml).
DRUGCyclosporin A (CsA)The dose was based on the participants' blood level of C0h (80-150 ng/ml).
DRUGTacrolimusThe dose was based on the participants' blood level of C0h (5-10 ng/ml).
DRUGEnteric Coated - Mycophenolate Sodium (EC-MPS)The dose was ≥ 720 mg/day.
DRUGCorticosteroidsCorticosteroids were given according to local standard and/or the Investigators' discretion.

Timeline

Start date
2005-11-01
Primary completion
2013-03-01
Completion
2013-03-01
First posted
2006-06-02
Last updated
2014-08-28
Results posted
2014-08-28

Locations

11 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT00332839. Inclusion in this directory is not an endorsement.